A
Aptose Biosciences Inc
NASDAQ:APTO
Aptose Biosciences Inc
NASDAQ:APTO
Price:
2.01
USD
17.54%
Market Closed
Market Cap:
$5.1m
Balance Sheet
Balance Sheet Decomposition
Aptose Biosciences Inc
Aptose Biosciences Inc
Balance Sheet Decomposition is not available for
Aptose Biosciences Inc
Aptose Biosciences Inc
Balance Sheet
Aptose Biosciences Inc
Aptose Biosciences Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
12
|
8
|
8
|
11
|
15
|
80
|
117
|
39
|
37
|
9
|
|
| Cash |
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
1
|
3
|
|
| Cash Equivalents |
12
|
8
|
8
|
11
|
15
|
78
|
117
|
39
|
36
|
6
|
|
| Short-Term Investments |
14
|
6
|
0
|
1
|
0
|
18
|
5
|
40
|
10
|
0
|
|
| Other Current Assets |
1
|
1
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
3
|
|
| Total Current Assets |
27
|
15
|
8
|
12
|
16
|
99
|
125
|
82
|
50
|
12
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
2
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
2
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
27
N/A
|
15
-44%
|
9
-44%
|
12
+38%
|
17
+41%
|
100
+496%
|
126
+26%
|
83
-35%
|
51
-38%
|
13
-75%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
2
|
1
|
2
|
1
|
2
|
2
|
2
|
6
|
3
|
|
| Accrued Liabilities |
1
|
0
|
0
|
0
|
1
|
3
|
5
|
6
|
6
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Liabilities |
2
|
2
|
1
|
2
|
3
|
6
|
7
|
8
|
12
|
15
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
|
| Total Liabilities |
2
N/A
|
2
-15%
|
1
-23%
|
2
+34%
|
3
+58%
|
7
+135%
|
7
+12%
|
8
+13%
|
13
+60%
|
16
+20%
|
|
| Equity | |||||||||||
| Common Stock |
190
|
212
|
218
|
232
|
261
|
365
|
430
|
437
|
438
|
445
|
|
| Retained Earnings |
187
|
221
|
235
|
247
|
276
|
302
|
357
|
423
|
464
|
516
|
|
| Additional Paid In Capital |
19
|
21
|
21
|
23
|
33
|
35
|
51
|
64
|
69
|
72
|
|
| Other Equity |
4
|
1
|
3
|
2
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Total Equity |
25
N/A
|
14
-46%
|
7
-46%
|
10
+39%
|
14
+38%
|
94
+567%
|
119
+27%
|
74
-38%
|
38
-49%
|
3
N/A
|
|
| Total Liabilities & Equity |
27
N/A
|
15
-44%
|
9
-44%
|
12
+38%
|
17
+41%
|
100
+496%
|
126
+26%
|
83
-35%
|
51
-38%
|
13
-75%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
